CHINA PHARMA HOLDINGS, INC. (CPHI) › Capital ExpendituresCHINA PHARMA HOLDINGS, INC. (CPHI) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: -$63.9K2011: -$352.4K2012: -$156.9K2013: -$18.79M2014: $5.13M2015: -$685.3K2016: $193.4K2017: $136.5K2018: $51.1K2019: $136.0K2020: $867.3K2021: $438.1K2022: $402.0K2023: $11.5K2024: $38.4K2025: $59.3K$59.3K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$59.3K+54.4%2024$38.4K+233.5%2023$11.5K-97.1%2022$402.0K-8.2%2021$438.1K-49.5%2020$867.3K+537.7%2019$136.0K+165.9%2018$51.1K-62.5%2017$136.5K-29.4%2016$193.4K+128.2%2015-$685.3K-113.4%2014$5.13M+127.3%2013-$18.79M-11880.2%2012-$156.9K+55.5%2011-$352.4K-451.8%2010-$63.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share